Related Experiment Video
Updated: Feb 13, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Tumor-Resident Streptococcus pneumoniae Promotes Malignant Progression and Pazopanib Resistance in Clear Cell Renal
Jinpeng Wang1,2, Yunfeng Nan1,2, Qing Liu2,3
1Department of Urology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Abstract:
Persistent drug resistance to tyrosine kinase inhibitors (TKI) has become a hurdle in extending the survival of patients with clear cell renal cell carcinoma (ccRCC). Through microbiome screening of patient samples from a ccRCC cohort treated with the TKI pazopanib, we identified Streptococcus pneumoniae as the dominant intratumoral microbiota in pazopanib-resistant ccRCC samples. Further investigation revealed that S. pneumoniae reprogrammed lipid metabolism in ccRCC cells by depleting manganese (Mn2+) from the tumor microenvironment, consequently facilitating malignant progression and development of pazopanib resistance. S. pneumoniae suppressed S-nitrosylation of tripartite motif-containing protein 28 (TRIM28) by diminishing Mn2+ levels, allowing TRIM28 to physically interact with the transcription factor SP1 to promote the transcription of solute carrier family 27 member 1 (SLC27A1) and lipid deposition. Taken together, these findings indicate that tumor-resident S. pneumoniae plays an important role in conferring pazopanib resistance, suggesting that S. pneumoniae could serve as a potential biomarker of pazopanib response in ccRCC.
Significance:
Streptococcus pneumoniae is an intratumoral bacteria that drives pazopanib resistance in renal cell carcinoma, highlighting the potential of targeting the tumor microbiome as a strategy to improve treatment outcomes in cancer patients.
Insights
Streptococcus pneumoniae in tumors drives pazopanib resistance in clear cell renal cell carcinoma (ccRCC) by altering lipid metabolism. This bacterium may serve as a biomarker for predicting patient response to this tyrosine kinase inhibitor.
Area of Science:
- Oncology
- Microbiology
- Metabolic Research
Background:
- Drug resistance to tyrosine kinase inhibitors (TKIs) limits survival in clear cell renal cell carcinoma (ccRCC).
- Intratumoral bacteria have been implicated in cancer progression and treatment response.
Purpose of the Study:
- To investigate the role of intratumoral microbiota in pazopanib resistance in ccRCC.
- To identify specific bacteria associated with treatment resistance and elucidate their mechanisms of action.
Main Methods:
- Microbiome screening of ccRCC patient samples treated with pazopanib.
- Analysis of lipid metabolism reprogramming and molecular pathways in ccRCC cells.
- Investigation of bacterial interactions with host cell proteins and metabolites.
Main Results:
- Streptococcus pneumoniae (S. pneumoniae) was identified as the dominant intratumoral bacterium in pazopanib-resistant ccRCC.
- S. pneumoniae depletes manganese (Mn2+), suppresses S-nitrosylation of TRIM28, and promotes lipid deposition via SP1/SLC27A1 axis.
- This reprogramming facilitates malignant progression and pazopanib resistance.
Conclusions:
- Tumor-resident S. pneumoniae contributes to pazopanib resistance in ccRCC by manipulating host lipid metabolism.
- S. pneumoniae represents a potential predictive biomarker for pazopanib response in ccRCC patients.
More Related Videos
06:29Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression
Published on: January 31, 2025
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Eukaryotic Promoter Region
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Noncompartmental Analysis: Mean Residence Time
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...